Bone biopsy confirmed DLBCL infiltration and an immunophenotypic analysis by flow cytometry showed CD19 dim expression on lymphoma cells (Fig. 1G) as compared with those before FC lymphodepletion chemotherapy (Fig. 1F). This evidence concerns the gene CD19 and diffuse large B-cell lymphoma.